SYNOVACEPT Trademark

Trademark Overview

On Wednesday, June 8, 2022, a trademark application was filed for SYNOVACEPT with the United States Patent and Trademark Office. The USPTO has given the SYNOVACEPT trademark a serial number of 97448794. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, June 27, 2024. This trademark is owned by Navidea Biopharmaceuticals, Inc.. The SYNOVACEPT trademark is filed in the Pharmaceutical Products category with the following description:

Radiopharmaceutical imaging and detection agents for diagnosing and monitoring rheumatoid arthritis
synovacept

General Information

Serial Number97448794
Word MarkSYNOVACEPT
Filing DateWednesday, June 8, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, June 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 2, 2023

Trademark Statements

Goods and ServicesRadiopharmaceutical imaging and detection agents for diagnosing and monitoring rheumatoid arthritis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNavidea Biopharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressColumbus, OH 43220
Party NameNavidea Biopharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDublin, OH 43017

Trademark Events

Event DateEvent Description
Saturday, June 11, 2022NEW APPLICATION ENTERED
Friday, June 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 22, 2023ASSIGNED TO EXAMINER
Saturday, March 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 12, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 2, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 2, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, December 6, 2023SOU EXTENSION 1 FILED
Tuesday, June 27, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 6, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 6, 2023SOU EXTENSION 1 GRANTED
Friday, December 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 11, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 27, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 27, 2024SOU EXTENSION 2 GRANTED
Thursday, June 27, 2024SOU EXTENSION 2 FILED
Monday, July 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 1, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, January 11, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

synovacept monitoring rheumatoid arthritis diagnosing agents imaging detection radiopharmaceutical